{"pub": "dailymail", "url": "https://dailymail.co.uk/news/article-7577035/Top-drug-distributors-pay-18billion-settle-opioid-lawsuits.html", "downloaded_at": "2019-10-15 23:16:00.281541+00:00", "title": "BREAKING: Top drug distributors 'to pay $18billion to settle opioid lawsuits'", "language": "en", "text": "Top drug distributors are in discussions to pay $18billion to settle opioid lawsuits, according to reports.\n\nMcKesson Corp., AmerisourceBergen Corp. and Cardinal Health Inc. would pay the money back over 18 years under the proposed deal, sources told The Wall Street Journal.\n\nThe litigation was brought by state and local governments who blamed the companies for fueling the opioid crisis.\n\nJohnson & Johnson is also thought to be part of talks to contribute more to the settlements.\n\nTop drug distributors are in discussions to pay $18billion to settle opioid lawsuits (stock image)\n\nThere are thousands of lawsuits connected to the prescription painkillers and their contribution to widespread opioid addiction.\n\nNearly 2,700 lawsuits blame OxyContin maker Purdue Pharma for helping spark the opioid crisis.\n\nIn the 1990s, overprescribing started the first wave of the nation\u2019s overdose crisis and opioids are now thought to be to blame for at least 400,000 deaths since 1999.\n\nJohnson & Johnson said Tuesday: 'We remain open to viable options to resolve these cases, including through settlement.'\n\nPurdue Pharma asked a U.S. Bankruptcy Judge on Friday to pause litigation against the company and its owners over the objections of U.S. states that allege the company is trying to protect the controlling Sackler family.\n\nPurdue's request promises to be one of the most contentious of the company's Chapter 11 bankruptcy case, which was filed in September to try to implement a settlement proposal it values at more than $10 billion.\n\nPrivately-held Purdue said last month it needed to pause more than 2,600 lawsuits so the company can reduce legal costs and try to win over more plaintiffs to its proposed deal.\n\nProtesters outside the McKesson Corp. annual meeting in Irving, Texas in July 2017\n\nOpioids \u2014 previously used mostly for patients with cancer, at the end of their lives or with pain after surgery \u2014 began to be prescribed for long-term pain such as backaches.\n\nDrug companies promoted that use, even as evidence grew of addiction and overdose.\n\nMcKesson, AmerisourceBergen and Cardinal Health are set to go to court in Cleveland, Ohio on Monday.\n\nThere was no comment from all three companies when approached by The Wall Street Journal.\n\nThe deal still needs to be agreed by attorneys representing plaintiffs.", "description": "McKesson Corp. , AmerisourceBergen Corp. and Cardinal Health Inc. would pay the money back over 18 years under the proposed\u00a0deal, according to reports.", "authors": ["Lauren Fruen For Dailymail.Com"], "top_image": "https://i.dailymail.co.uk/1s/2019/10/15/21/19759246-0-image-a-91_1571172616687.jpg", "published_at": "2019-10-15"}